Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency

65Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We have reported the clinical and biochemical findings in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. This paper is the first report about cardiomyopathy in jvs mice. Adult jvs mice (at the age of 2 3 months) show cardiac hypertrophy which is caused by enlargement of the cardiac muscle cell associated with increases of non-collagen protein and DNA content. Carnitine administration (2 mg/head, twice a day, from 1 month of age) significantly suppresses the cardiac hypertrophy, showing that carnitine deficiency plays an important role in the development of the cardiac hypertrophy. The discovery of cardiac hypertrophy in carnitine-deficient jvs mice will lead to clarification of the pathophysiology of cardiomyopathy in systemic carnitine deficiency in human beings. © 1993.

Cite

CITATION STYLE

APA

Horiuchi, M., Yoshida, H., Kobayashi, K., Kuriwaki, K., Yoshimine, K., Tomomura, M., … Saheki, T. (1993). Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Letters, 326(1–3), 267–271. https://doi.org/10.1016/0014-5793(93)81805-A

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free